3Theodore W, Kurtz, Michal Prawenec. Antidiabetic mechanisms of angiotensin_converting enzym inhibitors and angiotensin II receptor antagonists beyond the rennin_angiotensin system [J]. Journal o Hypertension, 2004, 22 (12) : 2253-2261.
4SavageDB, TanGD, AceriniCL, etal. Human metabolic syndrome resulting from dominant_negative mutationsin the nuclear receptor peroxisome proliferator_activated receptor-γ [J]. Diabetes, 2003, 52: 910-917.
5Pershadsingh HA. Peroxisome proliferator_activated receptor-therapeutic target for diseases beyond diabetes: Quo vadis[J] Expert Opin Invest Drugs, 2004, 13: 215-228.
6Berger J, Moller DE. The mechanisms of action of PPARs[J].Annu Rev Med, 2002, 53: 409- 435.
6Stephen C,Benson,et al.Identification of Telmisartan as a Unique Angiotensin ⅡReceptor Antagonist With Selective PPARγ-Modulating Activity[J].Hypertension,2004,43:993.
7Schild RL,Schaiff WT,Carlson MG,et al.The activity of PPAR gamma in primary human trophoblasts is enhanced by oxidized lipids[J].Clin Endocrinol Metab,2002,87(3):1105.
8Kawai M,Shiraishi M,lshii S,et al.3P-0701 A novel PPAR agonist,MCC-555,ameliorates endothelial cell dysfunction in vitro[J].Atherosclerosis,Supplements,2003,4(2):215.
